AL2 Impact is a privately held company that focuses on technologies that deliver improved outcomes for challenges confronting the world. We endeavor to develop low-cost, disruptive solutions that have an outsized impact in mature sectors of the economy. While our solutions impact all markets, we have a particular interest in making sure our solutions are practical in all economic situations, including low and middle-income countries. It is our belief that global solutions require access by all. Currently, AL2 is developing a novel technology to improve pathogen detection, including for COVID-19. We have substantially progressed a low-cost, easy-to-use, scalable, sensitive method of detecting COVID-19 for which we will soon submit for regulatory approval around the world.